Regenerating Skin for Life. Regenerative Medicine company with patented technology activating skin stem cells for new skin repair solutions
Genogen offers the opportunity for rapid entry into the burn, scar, skin repair, and anti-aging market. Product development is largely complete and studies in humans are underway. Product is a novel combination of two FDA approved drugs, minimizing safety concerns and the requirements to obtain FDA approval. Upon funding, it is estimated that the products will be introduced in 24-36 months. Expect revenue > $60M 3-5 years after funding event.